Soy
Avoid Soy harm
Edamame
Genistein (GEN)
Endocrine disruptor
Feeding soy protein isolate and n-3 PUFA affects polycystic liver disease progression in a PCK rat model of autosomal polycystic kidney disease.
J Pediatr Gastroenterol Nutr. 2015 Apr
Feeding a soy based diet resulted in complications of hepatic steatosis attributable to PLD liver
cysts obstruction of the bile duct and the hepatic vein.
To protect your liver and keep its size diminished, continue to avoid soy.
Neither
soy, flax seed or fish oil show benefit for PKD.
Soy Did NOT ↓ ARPKD
Soy Did NOT ↓ ARPKD
"As PKD advances, cyst growth increases kidney volume, decreases renal function, and may lead to end-stage renal disease; however, in a PKD rat model, feeding soy protein isolate (SPI) reduced cyst proliferation and growth. The n-3 polyunsaturated fatty acids (PUFAs) are noted for their anti-inflammatory actions. However in this study, soy did not attenuate disease progression or severity in the female PCK rat model of autosomal recessive PKD."
Soy
Soy (edamame) is not the health food that many believe. It is a strong estrogen disruptor equivalent to that found in clover. Both soy and clover contain the isoflavanoid Genistein (GEN) , a known estrogen disruptor. Many with PLD Polycystic Liver Disease have noticed that soy causes liver cysts to grow and expand.
↑ Liver cysts grow
↑ Interferes with thyroid functioning
↑ Endocrine disruptor
↑ Creates sterility by causing male infants testicles not to descend
↑ Risk of developing breast cancer
↑ Risk for prostate cancer
↑ Soy is among the top ten most allergic foods
↑ Phytoestrogens disrupt endocrine function
↑ Dementia
↑ Soy has many potent anti-thyroid agents, in vast quantities including Genistein
↑ Soy is said to possibly lower cholesterol perhaps the mechanism is soy's effect on the thyroid,
Soy Products
Soy products commonly used are:
soy sauce
tamari
edamame
soy oil
soy milk
soy yogurt
miso
soybean paste
soy oil
tempeh
tofu
soy burgers
soy hot dogs
soy lecithin
Bean sprouts
Bread crumbs
cereals
crackers
Breaded foods
Hydrolyzed plant protein (HPP)
hydrolyzed soy protein (HSP)
hydrolyzed vegetable protein (HVP)
Imitation dairy food
Infant formula
follow-up formula
nutrition supplements for toddlers and children
Meal replacements
Meat products with fillers
Mexican foods, chili, taco fillings and tamales,
Miso
Nutrition supplements
Sauces: shoyu, tamari, teriyaki, Worcestershire
Simulated fish and meat products: surimi, imitation bacon bits, vegetarian burgers
Stews: in gravies
Vegetarian dishes
Miso and miso soup are made from fermented soy. Soy is among the top ten allergic foods. Avoid these with PLD Polycystic Liver Disease as these are endocrine disruptors. Miso soup is made of kombu and miso.
Monsanto Soy
Monsanto genetically modified the soy bean to withstand a ton of roundup herbicide and the soy plant still remains standing. When asked by the European Union to please put this GM (genetically modified) soy aside so individuals might have a choice on which soy to eat, the USA boldly refused. Soybeans that are GM modified proliferate much more quickly than non GM soy. Soy is a potent super estrogen mimicker. When combined with another estrogen disruptor like with the weed killer, Roundup (or atrazine used on corn) is becomes a super endocrine disruptor. Monsanto soy combined with roundup, might be what is contributing to the increased estrogenic disruptive properties of soy and causing an increase in cystic liver growth from eating soy lecithin and its contamination of the ground water supply.
A few notes from older soy articles found in the pulldown menu below.
1986 Study from Cornell University, published in the Journal of the American College of Nutrition, 1986, which found that children who develop diabetes mellitus were twice as likely to have been fed soy.
1994 Evidence that disturbing results were omitted from a 1994 study presented to the FDA during the approval process for Roundup Ready Soybeans. Researchers found that raw Roundup Ready meal contained 27 percent more trypsin inhibitor and toasted Roundup Ready meal contained 18 percent more trypsin inhibitor compared to non-genetically manipulated controls.
1994 warning published in Pediatrics in which the Nutrition Committee of the American Academy of Pediatrics advised against the use of soy formulas due to the diabetes risk. These warnings have been neglected ever since it was reported that the AAP accepted a multi-dollar donation from the Infant Formula Council for their new headquarters building outside Chicago.
1994 article by Lonnerdal published in Acta Paediatr summarizing the reduced bioavailability of trace minerals due to high phytic acid content in soy infant formula; and high levels of manganese in soy formula compared to cows milk formula and breast milk. Excessive intake of manganese is linked to problems with the central nervous system.
1996 report published in the German magazine Klin Padiatr describing the development of hypocalcemic tetany in an infant fed soy formula.
1997 studies published in Nutrition and Cancer. One found that phytoestrogens at levels close to probable levels in humans stimulate cellular changes leading to breast cancer; the other found that dietary soy suppressed enzymes protective of breast cancer in mice.
1998 study published in the American Journal of Clinical Nutrition further confirming that soy-protein supplementation stimulates cell proliferation in human breast tissue.
1998 study published in Cancer Research which found that dietary genistein enhances the growth of mammary gland tumors in mice.
1998 study by Nagata and others published in the Journal of Nutrition daily consumption of tofu in Japan's Gifu prefecture as less than 1 gram per day.
1998 study published in Toxicology and Industrial Health indicating the phytoestrogens are potential endocrine disrupters in males.
1999 Daily Express article: Soy Allergy/Adverse Effect Rates Skyrocket - Monsanto's Roundup-Ready Soy Blamed
1999 study at the Clinical Research Center at MIT, published in the Proceedings of the Annual Meeting of the Pacific Coast Reproductive Society which found that estrogens in soy had no effect on menopausal symptoms such as hot flashes and night sweats.
1999 and June 2000 studies published in Brain Research indicating that phytoestrogens have adverse affects on brain chemistry.
2000 study published in Proceedings of the National Academy of Science which found that flavonoids, especially genistein, can cross the placenta and induce cell changes that lead to infant leukemia.
2000 which found lower testosterone levels and higher estrogen levels in Japanese men who consumed higher levels of soy foods.
Publication in the British Journal of Urology, January 2000, of the study showing a five-time greater risk of delivering a boy with hypospadias, a birth defect of the penis, in mothers who ate a vegetarian soy diets during pregnancy. The researchers attributed high rates of the birth defect to phytoestrogens in soy products.
2000 study published in Carcinogenesis found that soy feeding stimulated the growth of rat thyroid with iodine deficiency, partly through a pituitary-dependent pathway.
2000 article in American Journal of Cardiology which found that soy had no impact on lipid
levels in healthy postmenopausal women